Table 3 Patient baseline characteristics and delivered treatment
Median age (range) | 70 years (56-77) |
|---|---|
Clinical Stage | |
T1b | 1 (1%) |
T1c | 57 (71%) |
T2a | 22 (28%) |
Gleason Score | |
5 | 2 (2.5%) |
6 | 79 (97.5%) |
Median Initial PSA (range) | 5.9 ng/ml (0.81-9.89) |
Median prostate volume (range)* | 41 cc (10-90) |
Median Dose | 45 Gy |
Median Treatment Time | 57 days |